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ABSTRACT: Biomarkers of exposure to chemicals, such as styrene, allows to estimate the expo-
sure to a particular compound by measuring the compound or it(s) metabolite(s) in body fluids. 
As an example, the determination of mandelic acid and phenylglyoxylic acid in urine. Indicators of 
genotoxicity are categorized as: (a) DNA and protein adducts; (b) DNA strand breaks. Styrene meta-
bolism is initiated by Cytochrome P450 enzymes mediated by the oxidation of styrene to a reac-
tive metabolite, the styrene-7,8-oxide. This study aims to review the environmental monitoring, 
complemented with biomarkers of exposure in order to understand its correlation and styrene 
genotoxicity. Systematic searches were performed to identify studies of occupational exposure to 
styrene and health effects in workers of chemical industries. To determine styrene air concentra-
tion, several studies used a personal air sampling method. A significant correlation has been found 
between styrene air concentration and mandelic and phenylglyoxylic acid concentration in urine. 
A significant relationship was found between individual levels of mandelic acid and phenylglyo-
xylic acid and styrene-7,8-oxide adducts to N-terminal valine in hemoglobin among exposed indi-
viduals. A strong correlation was also found between the frequency of DNA single-strand breaks, 
in mononuclear leukocytes, and styrene airborne level. The relationship between DNA damage, 
persistence and repair is complex, which complicates the relevance evaluation of potential geno-
toxic exposures difficult. There is conflicting evidence on the relationship between genotoxic 
response and exposure level. In future individual susceptibility studies, the individual genotypes 
associated with the metabolic route and DNA damage of styrene (metabolizing enzymes and DNA 
repair enzymes) should be analyzed. From the analysis of several studies it was found that indeed 
there is a strong correlation between the exposure levels and exposure biomarkers; however, no 
evidence was found regarding the styrene genotoxicity.
Keywords: Occupational exposure, Styrene; Chemical industry, Styrene; Environmental and biological 
monitoring, Styrene; Exposure biomarkers, Styrene
Monitorização ambiental e biomarcadores de exposição ao estireno na 
indústria química
RESUMO: Os biomarcadores de exposição a químicos, como o estireno, indicam que a expo-
sição a um composto específico ocorre através da medição do composto inalterado ou do(s) seu(s) 
metabolito(s) nos fluídos corporais, como o ácido mandélico e o ácido fenilglioxílico presentes 
na urina. Os indicadores de genotoxicidade enquadram-se nas seguintes categorias: (a) adutos 
de proteínas e ADN; (b) quebras de ADN. O metabolismo do estireno é iniciado pelas enzimas do 
sistema citocromo P450, mediante a oxidação do estireno para um metabolito reativo, o 7,8-oxido 
de estireno. O presente estudo tem como objetivo a revisão de literatura relacionada com a 
monitorização ambiental do estireno e a existência de biomarcadores de exposição de forma a 
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compreender a sua correlação com a genotoxicidade do estireno. Realizaram-se pesquisas siste-
máticas para identificar estudos distintos de exposição ocupacional ao estireno e os seus efeitos 
na saúde de trabalhadores de indústrias químicas. Em resultado dessa pesquisa verificou-se que 
vários estudos referem a utilização de amostragem de ar pessoal para a determinação da concen-
tração de estireno. Uma forte e significativa correlação foi encontrada entre a concentração de 
estireno no ar e a concentração de ácido mandélico e o fenilglioxílico na urina. Uma correlação 
significativa entre os níveis individuais de ácido mandélico e fenilglioxílico e a presença de adutos 
de 7,8-oxido de estireno no N-terminal da valina da hemoglobina foi igualmente encontrada nos 
indivíduos expostos a concentrações mais elevadas de estireno. Estes adutos de 7,8-oxido de esti-
reno e hemoglobina persistem durante a vida útil dos eritrócitos. Estudos revelam também uma 
forte relação entre a frequência de quebras da cadeia simples do ADN nos leucócitos mononu-
cleares e o nível de estireno presente no ar. A relação entre as lesões, a sua persistência e a repa-
ração do ADN é complexa, o que dificulta a avaliação da relevância de potenciais exposições a 
substâncias genotóxicas. Existem evidências conflituantes da relação entre a resposta genotóxica 
e o nível de exposição. Como tal, os estudos sobre a suscetibilidade individual devem analisar e 
associar os genótipos individuais com a via metabólica do estireno e a lesão no ADN (metabo-
lizando enzimas e enzimas de reparação do ADN). Concluiu-se que existe uma forte correlação 
entre os níveis de exposição e os biomarcadores de exposição. No entanto, não foram encontradas 
provas quanto à genotoxicidade do estireno.
Palavras-chave: Exposição ocupacional, Estireno; Indústria química, Estireno; Monitorização ambiental 
e biológica, Estireno; Biomarcadores de exposição, Estireno
Introduction
Styrene and styrene plastics are indispensable to our 
modern world1. It is a colorless or slightly yellow liquid, that 
evaporates easily with a vapor pressure of 867 Pa at 25 °C2-3 
and it has a sweet smell4. 
It is widely used in the production of polystyrene plastics, 
protective coatings, styrene polyesters, copolymer resins and 
as a chemical intermediate2. 
Some products that contain styrene are fiberglass, plastic 
pipes, automobile parts, shoes, drinking cups and other food 
containers, and carpet backing4. 
Workers are exposed to styrene in several industries. Occu-
pational exposures occur during racking and handling of 
liquid styrene1, and so it is expected that production and 
maintenance workers are the most exposed at short-term5. 
Immediate exposure may cause symptoms such as vision 
impairment, fatigue and drowsiness, increase of reaction 
time, reduced focus and balance problems4. Styrene is poorly 
soluble in water, but highly soluble in fat. It can bind to rich 
lipid tissues such as brain, myelin, and adipose tissue6-8. 
Concerning the production of plastic and resins, 8-hour 
average samples in breathing zones often exceed styrene 
concentrations of 100 ppm9. The short-term effects start 
appearing at 20 ppm in 2-3 hours of exposure10. Some studies 
suggest that exposure to styrene concentration as low as 10 
ppm may induce health effects2.
Following the Portuguese Standard 1796, of 2014 
September, the occupational exposure limits (OELs) for 
Portugal is established as 20 ppm during 8-hour exposure 
and 40 ppm for 15 min exposure11.
The biomarkers indicate that exposure to a compound has 
occurred by measuring the compound or its metabolite(s) in 
body fluids12. Biomarkers of exposure can be separated into 
markers of effective dose, markers of effect and markers of 
internal dose12.
Several studies described relations between the concen-
tration in air and styrene metabolites levels in urine such as 
mandelic acid (MA) and phenylglyoxylic acid (PGA)13-16. 
Styrene metabolism is initiated by cytochrome P450, this 
enzyme mediates the oxidation of styrene to a reactive meta-
bolite styrene-7,8-oxide (SO)17. This intermediate is capable 
of binding covalently with macromolecules and is directly 
responsible for the genotoxic effects of styrene17. The geno-
toxicity of styrene depends on the ability of its epoxide, to 
interact with macromolecules including proteins and nucleic 
acids18. 
The genotoxicity of styrene has been extensively 
studied18-20. Indicators of potential genotoxicity fall into the 
following categories: (a) evidence that styrene exposure 
can increase the number of DNA and protein adducts; (b) 
evidence that styrene exposure can damage DNA by causing 
DNA strand breaks12. 
The carcinogenic potential of styrene stems largely from 
the ability of its metabolite, styrene-7,8-oxide, to bind cova-
lently to DNA and from its activity in a variety of genotoxicity 
test systems21.
This study aims to review the environmental monitoring, 
complemented with biological exposure biomarkers to 
understand its correlation and styrene genotoxicity. 
Methods
Systematic searches were performed (PubMed, selecting 
title, abstract, keywords) to identify studies of occupational 
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exposure to styrene and health effects, in chemical industries, 
using the following search terms:
a) Occupational exposure to styrene – health effects;
b) Environmental and biological monitoring;
c) Biomarkers of exposure to styrene. 
Studies were categorized as those that estimate: (1) envi-
ronmental monitoring of styrene; (2) health impacts of occu-
pational exposure to styrene; (3) assessing the occupational 
exposure with associations between biomarkers and environ-
mental monitoring.  
Twelve articles were selected by matching to our criteria 
and were excluded ten of the twenty-two analyzed; the 
studies that met our search criteria but did not provide infor-
mation on occupational exposure to styrene, environmental 
monitoring and biomarkers were excluded.
Results
Environmental monitoring
Air samples are collected in activated charcoal tubes, then 
are analyzed using gas chromatography22-25 after desorption 
with 2ml carbon disulfide according to the NIOSH method26-28. 
However, several other studies claim that the concentration 
of styrene in the air can be determined by spectrophoto-
metry29-32 and polarography33. Charcoal tubes are connected 
to battery-powered personal air sampling pumps operating 
at a flow rate of 100-200 ml/min27-28,40.
To determine the atmospheric styrene, several studies 
used a personal air sampling, performed in the breathing 
zone (near the upper respiratory tract) for significant working 
periods27-28,40.
Mandelic and phenylgly-oxylic acids in urine
In humans, the main route of metabolism of styrene is 
through cytochrome P450, originating styrene-7,8-oxide34-36. 
The epoxide is further hydrolyzed to styrene glycol by epoxide 
hydrolase, which is then oxidized to MA and PGA by alcohol 
and aldehyde dehydrogenases19.
Following inhalation, the half-life for styrene is 41 min in 
blood37 and 32-46 h in fat tissue38. The next morning measu-
rements reflect better past exposures due to the high fat solu-
bility of styrene15,39. 
Several studies recommend that urine samples should be 
collected twice, in the next morning and after work shift12,40. 
The urine samples should be analyzed on the day they 
were collected if possible, kept at 4 °C or more preferably at 
−20 °C40-41.
Obtained by linear regression (r≈0.9), a strong and signi-
ficant correlation has been found between the styrene air 
concentration and concentration of MA + PGA in urine2,28,40,42. 
Only one study claims that all urine samples from control 
subjects were below the limit of detection of the analytical 
methodology used for MA and PGA determination40.
A slightly significant relation was found between colour 
vision loss exams and the concentration of urinary MA and 
PGA2. This colour vision loss is considered acquired dyschro-
matopsia, the effect on visual function related to styrene 
exposure in the workplace43-46. The damage to visual function 
could reflect neural alterations in the peripheral system or a 
result of damage to ocular structures47-48.
DNA adducts
Substances that bind to DNA can cause DNA replication 
errors during cell division (mitosis), which may then be propa-
gated to additional lines of cells. The tendency of a substance 
to bind to DNA, to form ‘DNA adducts’, may be a useful indi-
cator of potential carcinogenic activity for several reasons. 
The result may be the development of cancer, depending on 
the nature of those errors49.  
Adduct persistence indicates that the carcinogenic poten-
tial activity varies according to adduct binding site, because 
cells have mechanisms for repairing adducts. Predominantly 
adducts bind to guanine at positions N7, N2, and O6, when 
DNA is directly exposed to SO42.  
In relation to controls (mean 13 pmol/g globin), increased 
levels of SO adducts to N-terminal valine in hemoglobin 
(SO-Hb) were observed in reinforced plastics workers (mean 
28 pmol/g globin)50. 
A significant correlation was found between the individual 
levels of MA+ PGA and the SO-Hb among exposed indivi-
duals12,27. A significant difference was also found in SO-Hb 
levels between workers with high exposure (average esti-
mated was 24 ppm) and controls. However at lower levels of 
exposure (7 ppm), SO-adducts in N-terminal valine of hemo-
globin were not detected51.
Between SO-adducts in N-terminal valine and concentra-
tion of styrene in the air, age and years of exposure no correla-
tion was obtained. These factors do not seem to influence the 
SO-Hb adducts levels, because SO-Hb adducts persist during 
the lifespan of erythrocytes, and their level is closely related 
to the concentration of SO in circulation12,27.
DNA breaks
The results obtained in styrene exposed workers studies 
suggest that styrene exposure leads to an increase of levels 
of DNA damage42,52-56, with an increase in DNA strand breaks 
in leukocyte DNA related with the exposure of workers to 
styrene57-58. 
A strong correlation has been described between the 
frequency of DNA single-strand breaks in mononuclear 
leukocytes and both the level of styrene exposure in the air 
and years of exposure to styrene12.
The ability of SO and styrene to induce DNA strand breaks 
in mammalian cells has been well documented both in 
vitro52,59 and in vivo55,57. However, because such breaks are 
quickly repaired, their significance as an indicator of toxicity 
is unclear52.
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Table 1. Samplings characterization of the analyzed studies
Sample Indicator References
Environmental Monitoring Personal air sampling
Styrene air 
concentration
27, 28, 40
Biomarkers of exposure
Internal dose Urine samples
Mandelic Acid (MA) 
phenylglyoxylic  Acid 
(PGA)
2, 28, 40, 42
Effective dose Blood samples
DNA adducts 
(SO-Hb)
12, 27, 51
Effect Blood samples DNA breaks 12, 52, 55, 57, 59
ding with some previous studies27,50,66. A very significant 
correlation between styrene concentrations in the workplace, 
styrene metabolites in urine and SO-Hb adduct measurement 
becomes a means of assessing exposure to styrene at occupa-
tional and environmental level27.
The DNA break provides information about temporary 
strand break. In normal circumstances, it gets repaired in a 
few hours before being fixed as a mutation12. The relationship 
between DNA damage, persistence and repair is complex 
and complicates the evaluation of the relevance of potential 
genotoxic exposures. It is likely that there is a level of DNA 
damage which does not have any biological significance due 
to repair but there is no understanding of what this level is for 
individual genotoxic60.
There is conflicting evidence for a relationship between 
genotoxic response and exposure level60. Furthermore, the 
genotoxic potential of styrene in humans is predicted to be 
lower than in rats and mice due to a lower rate of SO forma-
tion from styrene and a more efficient conversion of SO into 
water-soluble metabolites, resulting in lower blood levels of 
SO67.
Because of the inconsistent and predominantly weak effects 
which have been reported for the genotoxicity of styrene in 
humans, several studies investigate the influence of genetic 
polymorphisms to find whether styrene is an in vivo mutagen 
through the possible identification of susceptible individuals 
with higher levels of damage due to their differences in acti-
vation and inactivation of styrene60.
Genetic diversity is clearly important in influencing indivi-
dual susceptibility to carcinogens12. Surely, gene–gene inte-
ractions and gene–environment interactions are fundamental 
to the interpretation and use of susceptibility biomarkers, so 
studies of individual susceptibility should analyze the indivi-
dual genotypes associated with the metabolic route and DNA 
damage of styrene (metabolizing enzymes and DNA repair 
enzymes)12.  
From the analysis of several studies it was found that 
indeed there is a strong correlation between the exposure 
levels and exposure biomarkers; however, no evidence was 
Discussion
Concerning to the environmental monitoring, the personal 
dosimeters obviously provide a more relevant exposure para-
meter on an individual basis than static monitors. Both of 
techniques lack in detecting exposure peaks, which may be 
the critical factor in the induction of biological effects when 
the average workplace styrene levels are kept within expo-
sure limits60. That is, if styrene were genotoxic in vivo, then it 
would be expected that studies with higher levels of exposure 
would be more likely to be positive and that different levels of 
response would occur in relation to different exposures inside 
a study population60.
The measurements of MA and PGA are routinely used as 
biological control27 of styrene exposure worldwide12. These 
metabolites are rapidly changed and thus can only be used 
to indicate recent exposure and give the most precise infor-
mation of individual’s exposure and consider the personal 
protection equipment60.
Overall, for humans, 2.6% of absorbed styrene is excreted in 
an unchanged state in urine, 85% as urinary MA and 10% as 
urinary PGA and 5% in the exhaled air61.
The concentration of MA in urine that corresponds to an 8h 
exposure to 50 ppm (213mg/m3) styrene would be expected 
to be 800-900mg/g creatinine at the end of a shift and 
300-400mg/g creatinine the following morning14,16,62. The PGA 
concentration in urine that corresponds to an inhalation of 50 
ppm styrene for 8h would be approximately 200-300mg/g 
creatinine at the end of a shift and about 100mg/g creatinine 
the following morning16,61.
A significant correlation was found between styrene 
concentrations in inhaled air and its urinary metabolites27,42,63. 
Furthermore, results showed a more significant correlation 
with styrene concentrations in inhaled air if the urine samples 
were collected in the morning following the exposure to 
measure MA and PGA, than the determination of MA alone, 
which is usually undertaken after the work-shift15,64.
It was observed that SO-Hb adducts were significantly 
higher in exposed subjects as compared to controls and 
correlated with internal dose parameter (MA and PGA) accor-
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found regarding the styrene genotoxicity and therefore, it is 
necessary to conduct further studies on the use of susceptibi-
lity biomarkers to find genotoxicity evidence.
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